Discover Keynote Speakers at the 2026 ISPE AI in Life Sciences Summit in Boston
The International Society for Pharmaceutical Engineering (ISPE) is set to host its inaugural AI in Life Sciences Summit on June 22-23, 2026, in Boston, Massachusetts, and online. This groundbreaking summit aims to address the integration of artificial intelligence (AI) within the life sciences sector, highlighting crucial themes such as governance, validation, and the organizational readiness required in regulated environments.
As AI continues to shape the future of various industries, the life sciences field is no exception. The 2026 ISPE Summit is poised to provide more than just a platform for discussion; it will feature a robust lineup of keynote speakers and dedicated tracks focusing on the practical implementation of AI in pharmaceutical operations.
Nick Armstrong, an Associate Director at IPS, who also serves as the Conference Chair for this event, emphasizes, "The future of AI in regulated environments will not be defined by how quickly organizations deploy new technologies, but by how thoughtfully and systematically they govern them." This statement encapsulates the summit's mission: to elevate the conversation around AI from mere enthusiasm to structured, engineered maturity.
The conference will encompass four distinct technical tracks:
1. Case Studies in Process Control and Manufacturing Design: This track will delve into real-world applications where AI has made a significant impact on enhancing operational efficiencies in drug manufacturing and process control.
2. Workforce Preparedness and Organizational Readiness: Preparing personnel to embrace new technologies is vital, and this track focuses on how organizations can best equip their teams.
3. Case Studies in Implementation: Attendees will learn from practical implementations of AI, exploring the successes and challenges faced in various case studies within the industry.
4. Validation and GAMP: This track will concentrate on the validation processes critical to the pharmaceutical industry, particularly how AI tools can align with GxP requirements and regulatory frameworks.
The keynote speakers for the event are an impressive array of experts, including:
Through these sessions and case-study discussions, the summit is designed to equip industry professionals with actionable insights necessary for navigating the evolving landscape of AI adoption. By bringing together regulatory, technical, and operational specialists, the summit aims to foster responsible innovations that enhance quality, compliance, and patient safety.
For those interested in participating, details to learn more and register for the summit can be found at ISPE.org/26Summit. As a global nonprofit association, ISPE has dedicated itself to the advancement of scientific, technical, and regulatory aspects throughout the pharmaceutical lifecycle, serving more than 25,000 members worldwide. Founded in 1980, ISPE aims to tackle complex challenges within the pharmaceutical sector through collaboration and innovation.
Don’t miss out on this unique opportunity to be part of critical discussions shaping the future of AI in life sciences. The 2026 ISPE AI in Life Sciences Summit is your chance to connect with experts and thought leaders, all working towards a more responsible and strategically sound approach to AI in regulated environments.
As AI continues to shape the future of various industries, the life sciences field is no exception. The 2026 ISPE Summit is poised to provide more than just a platform for discussion; it will feature a robust lineup of keynote speakers and dedicated tracks focusing on the practical implementation of AI in pharmaceutical operations.
Nick Armstrong, an Associate Director at IPS, who also serves as the Conference Chair for this event, emphasizes, "The future of AI in regulated environments will not be defined by how quickly organizations deploy new technologies, but by how thoughtfully and systematically they govern them." This statement encapsulates the summit's mission: to elevate the conversation around AI from mere enthusiasm to structured, engineered maturity.
The conference will encompass four distinct technical tracks:
1. Case Studies in Process Control and Manufacturing Design: This track will delve into real-world applications where AI has made a significant impact on enhancing operational efficiencies in drug manufacturing and process control.
2. Workforce Preparedness and Organizational Readiness: Preparing personnel to embrace new technologies is vital, and this track focuses on how organizations can best equip their teams.
3. Case Studies in Implementation: Attendees will learn from practical implementations of AI, exploring the successes and challenges faced in various case studies within the industry.
4. Validation and GAMP: This track will concentrate on the validation processes critical to the pharmaceutical industry, particularly how AI tools can align with GxP requirements and regulatory frameworks.
The keynote speakers for the event are an impressive array of experts, including:
- - Michael Abernathy, Associate Vice President of Regulatory Affairs at Amgen Inc.
- - Jennifer Bromm, Senior Project Manager at DEKRA
- - Marcel Geers, Associate Partner at Porsche Consulting
- - Xia Huang, PhD, Project Manager at DEKRA
- - Bill Reid, Healthcare and Life Sciences Lead at Google
Through these sessions and case-study discussions, the summit is designed to equip industry professionals with actionable insights necessary for navigating the evolving landscape of AI adoption. By bringing together regulatory, technical, and operational specialists, the summit aims to foster responsible innovations that enhance quality, compliance, and patient safety.
For those interested in participating, details to learn more and register for the summit can be found at ISPE.org/26Summit. As a global nonprofit association, ISPE has dedicated itself to the advancement of scientific, technical, and regulatory aspects throughout the pharmaceutical lifecycle, serving more than 25,000 members worldwide. Founded in 1980, ISPE aims to tackle complex challenges within the pharmaceutical sector through collaboration and innovation.
Don’t miss out on this unique opportunity to be part of critical discussions shaping the future of AI in life sciences. The 2026 ISPE AI in Life Sciences Summit is your chance to connect with experts and thought leaders, all working towards a more responsible and strategically sound approach to AI in regulated environments.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.